ArticleAmerican journal of clinical dermatology2022
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System.
Emanuel Raschi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papercites it